Domain II mutants of anthrax lethal factor

Details for Australian Patent Application No. 2005292200 (hide)

Owner Van Andel Research Institute

Inventors Duesbery, Nicholas S.

Agent Griffith Hack

Pub. Number AU-A-2005292200

PCT Pub. Number WO2006/039707

Priority 60/614,555 01.10.04 US

Filing date 3 October 2005

Wipo publication date 13 April 2006

International Classifications

C07K 14/32 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/039707 Priority application(s): WO2006/039707

6 September 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Aug 2007

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005292202-Methods using glycosaminoglycans for the treatment of kidney disease

2005292185-Modified release ibuprofen dosage form